Rm. Thomas et al., INFLAMMATORY PSEUDOTUMOR OF THE SPLEEN - A CLINICOPATHOLOGICAL AND IMMUNOPHENOTYPIC STUDY OF 8 CASES, Archives of pathology and laboratory medicine, 117(9), 1993, pp. 921-926
Citations number
18
Categorie Soggetti
Pathology,"Medical Laboratory Technology","Medicine, Research & Experimental
We report the clinical, pathologic, and immunophenotypic findings of i
nflammatory pseudotumors of the spleen in eight patients. The primary
importance of recognizing these uncommonly found lesions is to disting
uish them from malignant lymphoma, which splenic inflammatory pseudotu
mors may mimic clinically and radiologically. Grossly, the splenic inf
lammatory pseudotumors in this study ranged from 0.5 to 11.5 cm. One c
ase was multinodular, and seven lesions were solitary. In general, the
size of the lesion correlated with the presence of symptoms. The smal
ler lesions were usually incidental findings, discovered as part of th
e workup of idiopathic thrombocytopenic purpura (three cases), during
staging for Hodgkin's disease (one case), or at autopsy (one case). Mi
croscopically, the lesions were composed of a variable mixture of infl
ammatory cells admixed within a spindle cell proliferation. Small, cyt
ologically normal lymphocytes and plasma cells were constant features,
in a variable mixture, with neutrophilic and eosinophilic leukocytes
present in some cases. Coagulative necrosis was located centrally in s
ix lesions; neutrophilic leukocytes were correlated with the presence
of necrosis. The presence of necrosis did not correlate with the prese
nce of symptoms. Immunohistochemical studies revealed that the small l
ymphocytes present were predominantly T cells. Histiocytes and polytyp
ic plasma cells were also numerous, whereas B cells were infrequent. I
nflammatory pseudotumors of the spleen are benign lesions. The clinica
l follow-up for the seven patients in this study who underwent splenec
tomy showed no evidence of recurrence or subsequent development of a h
ematopoietic neoplasm, with a median follow-up of 18 months (range, 3
to 135 months).